Tadeu D. Ramos
Rio De Janeiro, RJ 21040360, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Efficacy of LaAg Vaccine Associated with Saponin Against Leishmania amazonensis Infection.
Journal: Vaccines
Published: August 21, 2024
IL-17A/IFN-γ producing γδ T cell functional dichotomy impacts cutaneous leishmaniasis in mice.
Journal: Journal of leukocyte biology
Published: May 06, 2024
Potential of extracellular vesicles in the pathogenesis, diagnosis and therapy for parasitic diseases.
Journal: Journal of extracellular vesicles
Published: February 22, 2024
MPLA and AddaVax® Adjuvants Fail to Promote Intramuscular LaAg Vaccine Protectiveness against Experimental Cutaneous Leishmaniasis.
Journal: Microorganisms
Published: January 30, 2021
Combined therapy with adipose tissue-derived mesenchymal stromal cells and meglumine antimoniate controls lesion development and parasite load in murine cutaneous leishmaniasis caused by Leishmania amazonensis.
Journal: Stem cell research & therapy
Published: May 27, 2020
Characterization of Sv129 Mice as a Susceptible Model to Leishmania amazonensis.
Journal: Frontiers in medicine
Published: January 31, 2019
Dietary Vitamin D3 Deficiency Increases Resistance to Leishmania (Leishmania) amazonensis Infection in Mice.
Journal: Frontiers in cellular and infection microbiology
Published: January 15, 2019
Immunomodulating role of IL-10-producing B cells in Leishmania amazonensis infection.
Journal: Cellular immunology
Published: June 02, 2018
The role of TLR9 on Leishmania amazonensis infection and its influence on intranasal LaAg vaccine efficacy.
Journal: PLoS neglected tropical diseases
Published: May 13, 2018
Last Updated: 09/26/2026